ArticleFrontiers in immunology2026
Role of PBAF and Mediator kinase module in the RELA-dependent activation of
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The transcription of inflammatory genes is rapidly induced by extracellular stimuli through coordinated actions of transcription factors and large coactivator complexes. However, the mechanistic interplay between specific chromatin remodelers and kinase modules in driving the transcriptional burst of early inflammatory genes remains poorly understood. This study investigates the roles of the PBAF chromatin remodeling complex and the Mediator kinase module (MKM) in activating NF-κB-dependent CXCL1, CXCL2, and CXCL3 chemokine genes. Methods: We employed a combination of molecular and genomic techniques. Protein-protein interactions were analyzed via co-immunoprecipitation (co-IP). Transcriptional outputs of CXCL1-3 genes were measured by quantitative mRNA analysis. Chromatin immunoprecipitation (ChIP) was used to assess the occupancy of RNA polymerase II (Pol II), its elongating form (Pol II-S2P), the MKM subunit CDK8, and the PBAF complex (via its BAF200 subunit) at target gene promoters. Functional contributions of the complexes were dissected using siRNA-mediated knockdown of BAF200 (PBAF) and small-molecule inhibition of the MKM. Results: PBAF and MKM physically interact with each other and with the NF-κB subunit RELA, and both complexes additively contribute to the transcriptional activation of CXCL1-3 genes. Knockdown of the PBAF-specific subunit BAF200 resulted in the loss of the entire PBAF complex from chromatin, a reduction in total Pol II and CDK8 promoter occupancy, and consequently, impaired gene induction. In contrast, MKM inhibition did not affect PBAF recruitment but specifically reduced the level of elongating Pol II-S2P and transcriptional activation. These data indicate non-redundant, stage-specific functions. Discussion: Our results demonstrate that the PBAF complex and the Mediator kinase module regulate distinct, sequential steps in the transcription cycle of CXCL1-3 genes. PBAF is critical for the initial promoter recruitment or stabilization of the transcription machinery, while MKM primarily facilitates the transition into productive elongation. Their additive positive effect and physical interaction suggest a coordinated mechanism where PBAF establishes a permissive chromatin context, enabling subsequent MKM-dependent phosphorylation events that drive the transcriptional burst of key inflammatory chemokines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.